Shares of Qualys, Inc. (QLYS) are plunging 25% to $41.10 in early trading on Tuesday after the cybersecurity company late on Monday lowered its fiscal 2015 revenue guidance and posted a disappointing outlook. Redwood City, California-based Qualys guided Q2/15 revenues of $39.5 – $40 million, as compared to analysts’ expectations of $40.72 million. The management also gave its bottom line range of $0.09 – $0.11 per share, against projections of $0.13 per share.
AcelRx Pharmaceuticals, Inc. (ACRX) shares are down nearly 24% to $3.19 after Tuesday’s open following news company’s request for a Type B meeting with the FDA was denied and the division restated its view that a clinical study is required.
In other ACRX news this morning, the name had its price target lowered to $7 from $8 at RBC Capital Markets.
Golar LNG Ltd. (GLNG) shares climbed 19.47% to $44.92 after the company annouced today that it has commenced discussions with partners Keppel and Black & Veatch aimed at exercising an option, under an existing framework agreement, for the ordering of a third GoFLNG unit similar to the Hilli and the Gimi.
GLNG’s trading volume has jumped on the news with the issue currently trading more than 2.6 million shares, compared to the average volume of 1.54 million.
Westport Innovations Inc. (WPRT) has gained 12.39% to $5.85 in early trading after the company today announced plans to offer 2016 Ford F-150 trucks for use with the compressed natural gas (CNG) Westport WiNG™ Power System, and certify to EPA and CARB standards. Westport said the first 2016 F-150 featuring the Westport WiNG™ Power System will be unveiled today at the Alternative Clean Transportation (ACT) Expo in Dallas, Texas, and is expected to be available for order this summer.
Clean Diesel Technologies Inc. (CDTI) shares are up 30% to $2.38 in early trading. The move comes on a big volume too with the issue currently trading more than 2.7 million shares, well above the average of 152K shares for a full session over the past month.
Clean Diesel Technologies today released preliminary engine and vehicle test results for its new synergized-platinum group metal (SPGM™) diesel oxidation catalyst (DOC) technology. In these initial tests, CDTi’s SPGM™ DOC achieved emission control and system performance comparable to a leading original equipment manufacturer (OEM) catalyst product while slashing PGM usage by over 80%.
Clean Diesel said the SPGM DOC technology represents another breakthrough in CDTi’s advanced materials research program aimed at significantly reducing or eliminating the need for costly PGMs in emission control catalysts.
Shares of PlasmaTech Biopharmaceuticals (PTBI) spiked nearly 60% to $4.51 on Tuesday, giving it a market cap of roughly $91 million, following news of George Soros’s Fund Management taking a new 5.17% stake in the company.
About 12 million shares have exchanged hands as of 10:35 a.m. ET today, compared to its average trading volume of about 128K shares a day
Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!
Leave a Reply